To elucidate the local effects oi renin in the coronary circulation, w
e examined local angiotensin (Ang) I and II formation, as well as coro
nary vasoconstriction in response to renin administration, and compare
d the effects with exogenous infused Ang I. We perfused isolated heart
s from rats overexpressing the human angiotensinogen gene in a Langend
orff preparation and measured the hemodynamic effects and the released
products. We also investigated cardiac Ang I conversion, including th
e contribution of non-angiotensin-converting enzyme-dependent Ang II-g
enerating pathways. Finally, we studied Ang I conversion in vitro in h
eart homogenates. Renin and Ang I infusion both generated Ang II. Ang
II release and vasoconstriction continued after renin infusion was sto
pped, even though renin disappeared immediately from the perfusate. In
contrast, after Ang I infusion, Ang II release and coronary now retur
ned to basal levels. Ang I conversion (Ang II/Ang I ratio) was higher
after renin infusion (0.109+/-0.027 versus 0.026+/-0.003, 15 minutes,
P<.02) compared with infused Ang I. Remikiren added to the renin infus
ion abolished Ang I and II; captopril suppressed only Ang II, whereas
an AT, receptor blocker did not affect Ang I and II formation. All the
drugs prevented renin-induced coronary now changes. Total cardiac Ang
II-forming activity was only partially inhibited by cilazaprilat (4.1
+/-0.1 fmol.min(-1).mg(-1)) and on a larger extent by chymostatin (2.6
+/-0.3 fmol.min(-1).mg(-1)) compared with control values (5.6+/-0.4 fm
ol.min(-1).mg(-1)). We conclude that renin can be taken up by cardiac
or coronary vascular tissue and induces long-lasting local Ang II gene
ration and vasoconstriction. Locally formed Ang I was converted more e
ffectively than infused Ang I. Furthermore, the comparison of in vivo
and in vitro Ang I conversion suggests that in vitro assays may undere
stimate the functional contribution of angiotensin-converting enzyme t
o intracardiac Ang II formation.